Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Sapiens International Corporation N.V. - | S3P | Nov 15, 2024 | 26.60 | -0.75 |
Sappi Ltd | SPI | Nov 15, 2024 | 2.62 | -0.76 |
Sappi Ltd | SPIA | Nov 15, 2024 | 2.52 | -0.79 |
Sapporo Holdings Ltd. | SBW | Nov 15, 2024 | 47.80 | +3.02 |
Saputo Inc | SB7 | Nov 15, 2024 | 17.77 | +0.74 |
Sarama Resources Ltd | 48S1 | Nov 15, 2024 | 0.01 | +4.00 |
SARATOGA INVES.SED.RP 100 | ZY8 | 0.00 | 0.00 | |
Sarepta Therapeutics, Inc. | AB3A | Nov 15, 2024 | 102.40 | -4.70 |
Sareum Holdings Plc | RYH0 | Nov 15, 2024 | 0.26 | 0.00 |
Sartorius AG | SRT | Nov 15, 2024 | 182.40 | -1.19 |
Sartorius AG PRF PERPETUAL EUR | SRT3 | Nov 15, 2024 | 218.50 | -4.59 |
Sartorius AG UNsponsored ADR (Germany) | SRT0 | Nov 15, 2024 | 44.20 | +0.91 |
Sartorius Stedim Biotech, Aubagne Ordinary Shares | 56S1 | Nov 15, 2024 | 181.25 | -0.41 |
Sasol Ltd | SAOA | Nov 15, 2024 | 4.76 | -4.80 |
Sasol Ltd. American Depositary Shares | SAO | Nov 15, 2024 | 4.76 | -2.86 |
SASQUATCH RESOURCES CORP. | NQ0 | Nov 15, 2024 | 0.04 | -1.12 |
Sassy Gold | 123 | Nov 15, 2024 | 0.06 | 0.00 |
Satellos Bioscience Inc | 0ITA | Nov 15, 2024 | 0.54 | -0.93 |
SATS | 2S0 | Nov 15, 2024 | 2.00 | +1.42 |
SATS Ltd. | W1J | Nov 15, 2024 | 2.60 | +1.56 |
Saturn Oil & Gas Inc | SMKA | Nov 15, 2024 | 1.39 | +3.42 |
Saul Centers, Inc. | SA4 | Nov 15, 2024 | 37.00 | -0.54 |
Savannah Resources Plc | SAV | Nov 15, 2024 | 0.04 | -4.44 |
Savara, Inc. | YB4P | Nov 15, 2024 | 2.88 | -4.64 |
Savaria Corp. | S97 | Nov 15, 2024 | 14.70 | +1.38 |
SaveLend Group AB | 70D | Nov 15, 2024 | 0.19 | +0.53 |
Savencia S.A. | BGJ | Nov 15, 2024 | 50.00 | 0.00 |
Saville Resources | S0J0 | Nov 15, 2024 | 0.16 | 0.00 |
Savills PLC | 1YZ | Nov 15, 2024 | 12.60 | +2.44 |
Savosolar | 5J4 | Nov 15, 2024 | 0.02 | -2.68 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.